Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
AOL

House Spiders Go High-Tech: CRISPR Swaps DNA for Dazzling Red Silk

The possibility of editing our genes once seemed more like science fiction than reality. Times have changed with the development of CRISPR-Cas9, a gene-editing tool first used in 2012. Gene editing is ...
JD Supra

Federal Circuit Revives CRISPR-Cas9 Patent Priority Dispute

UC and Broad have been involved in two interferences at the patent office. Interference No. 106,115 was the second interference between UC and Broad over patent rights to CRISPR-Cas9 technology in ...